Hotaling Investment Management, LLC Gilead Sciences, Inc. Transaction History

Hotaling Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 22, 2021	SELL	$56.65 - $64.55 $687,674 - $783,572	-12,139 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $12,730 - $16,006	-205 Reduced 1.66%	12,139 $767,000
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $10,127 - $11,760	140 Added 1.15%	12,344 $950,000
Q1 2020 Apr 08, 2020	SELL	$62.63 - $80.22 $43,277 - $55,432	-691 Reduced 5.36%	12,204 $912,000
Q4 2019 Jan 28, 2020	BUY	$61.62 - $67.78 $794,589 - $874,023	12,895 New	12,895 $838,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hotaling Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hotaling Investment Management, LLC with notifications on news.